Latest Innovation News

EVE Health Group has transitioned from development to commercial rollout, delivering first patient prescriptions of Dyspro™ and completing initial manufacturing of Libbo™, supported by a $1.1 million capital raise.

Thrive Tribe Technologies reported a $186,000 net operating cash outflow in Q2 FY26, offset by a $300,000 equity raise to fund growth initiatives and operational expansion.

InFocus Group Holdings Limited has formalised its strategic expansion into iGaming and digital assets, appointing a high-profile advisory board and strengthening its capital position through convertible notes and Bitcoin ETF investments.

333D Ltd reports continued revenue growth in digital asset management and unveils a pioneering blockchain solution for MRI data storage, reinforcing its foothold in digital healthcare.

State Gas Limited has independently certified a maiden 2P gas reserve of 30.2 PJ at its Rolleston West Project, underpinning plans for a 10TJ/day gas development. The company also raised $3.2 million through convertible notes to accelerate pre-development activities.

Talga Group has reported a quarter of significant commercial and regulatory progress, including its largest anode shipment, expanded product offerings, and major mining approvals in Sweden, supported by substantial capital raises and new patents.

Hartshead Resources NL has entered a binding agreement to be acquired by ACAM for approximately A$40 million, offering shareholders a 133% premium and certainty amid UK gas project risks. The deal advances development of the P2607 gas fields with strong backing from partners and regulators.

1414 Degrees has made significant strides in developing its Aurora Energy Precinct, securing crucial regulatory approvals for its battery storage system and progressing its battery materials and hydrogen technologies.

Minbos Resources advances key financing deals and unveils a cost-cutting plan for its Cabinda Phosphate Project, while forming a strategic joint venture to develop green ammonia production targeting 2028.

Recce Pharmaceuticals progresses its Phase 3 diabetic foot infection trial in Indonesia, reports promising preclinical data for inhaled RECCE 327, and secures significant R&D funding and patent protection.

Adherium Limited has exceeded its 2025 shipment goals for its Hailie Smartinhaler devices, driven by rapid growth in remote patient monitoring activations and improved US Medicare reimbursement policies.

PARKD Limited has commissioned its new prefabrication facility in Penrith, successfully delivered a pilot project with McNab Group, and secured $1 million in capital to fuel its east-coast growth strategy.